ImmunoReagents and AmyJet Scientific will partner to distribute top quality antibodies to the Chinese biotech, life science, and medical communities. China is rapidly becoming a global power in the biotechnology industry. China had more than 580 biopharma companies in 2009, and as of 2011 it had more than 5,000 pharmaceutical companies (MMLC Group, 2009; KMPG, 2011). According to CNN, the Chinese government will be spending $308 billion on biomedicine over the next five years.
"This is an exciting partnership for our company." said Ann Black, President and CEO of ImmunoReagents. "Our collaboration with AmyJet Scientific will introduce our products into one of the largest and fastest growing biotech markets in the world.”
ImmunoReagents is a leading global manufacturer of quality polyclonal antibodies used in research and in vitro diagnostics. They offer a wide range of secondary antibodies covering a broad spectrum of immunoglobulins from various species. Antibodies include various levels of cross species absorptions to provide high specificity. The Company also manufactures primary polyclonal antibodies to hormones, cancer markers, cardiac markers and serum proteins. In addition to its vast product lines, ImmunoReagents also provides custom manufacturing to meet specific customer requirements while adhering to cGMP guidelines and ISO quality systems requirements. The Company is located on NCSU’s Centennial Campus, the University-owned and operated research park and technology campus.
More information about ImmunoReagents:
About AmyJet Scientific
AmyJet Scientific provides scientific reagents, technical services, and contract development for specialized high-tech companies. The company aims to provide top quality products and services for the development of life science products and services in the fields of biotechnology and biopharmaceuticals, including the development and production of diagnostic reagents.
More information about AmyJet Scientific: http://www.amyjet.com/